- Previous Close
101.14 - Open
101.38 - Bid --
- Ask --
- Day's Range
100.06 - 101.80 - 52 Week Range
78.53 - 104.55 - Volume
457,600 - Avg. Volume
682,040 - Market Cap (intraday)
10.149B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
22.45 - EPS (TTM)
4.49 - Earnings Date Apr 22, 2025 - Apr 28, 2025
- Forward Dividend & Yield 0.68 (0.67%)
- Ex-Dividend Date Apr 1, 2025
- 1y Target Est
117.25
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
www.encompasshealth.com23,564
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHC
View MorePerformance Overview: EHC
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHC
View MoreValuation Measures
Market Cap
10.15B
Enterprise Value
12.78B
Trailing P/E
22.45
Forward P/E
20.70
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
4.91
Enterprise Value/Revenue
2.38
Enterprise Value/EBITDA
10.77
Financial Highlights
Profitability and Income Statement
Profit Margin
8.48%
Return on Assets (ttm)
8.65%
Return on Equity (ttm)
23.29%
Revenue (ttm)
5.37B
Net Income Avi to Common (ttm)
455.7M
Diluted EPS (ttm)
4.49
Balance Sheet and Cash Flow
Total Cash (mrq)
85.4M
Total Debt/Equity (mrq)
95.25%
Levered Free Cash Flow (ttm)
215.84M